Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases β and η

DNA Repair

Volumn 1, Issue 12, 2002, Pages 1003-1016

  Bassett, Ekaterina ^a   Vaisman, Alexandra ^a   Tropea, Kristen A ^a   McCall, Chad M ^a   Masutani, Chikahide ^b   Hanaoka, Fumio ^b,c   Chaney, Stephen G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c RIKEN   (Japan)

Author keywords

Cisplatin; DNA polymerase ; DNA polymerase ; Frameshift; Oxaliplatin; Translesion synthesis

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; PLUTONIUM;

ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA FLANKING REGION; DNA SYNTHESIS; FRAMESHIFT MUTATION; GENE DELETION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MUTAGENESIS; PRIORITY JOURNAL;

BASE SEQUENCE; CISPLATIN; DNA ADDUCTS; DNA DAMAGE; DNA POLYMERASE BETA; DNA REPAIR; DNA-DIRECTED DNA POLYMERASE; FRAMESHIFT MUTATION; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTAGENS; ORGANOPLATINUM COMPOUNDS; RECOMBINANT PROTEINS; SEQUENCE DELETION;

EUKARYOTA;

EID: 0037027854     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-7864(02)00150-7     Document Type: Article

References (43)

1. Eastman A. The formation. Pharmacol. Ther. 34:1987;155-166.
2. Woynarowski J.M., Chapman W.G., Napier C., Herzig M.C.S., Juniewicz P. Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA. Mol. Pharmacol. 54:1998;770-777.
3. Greene M.H. Is cisplatin a human carcinogen? J. Natl. Cancer Inst. 84:1992;306-312.
4. Leopold W.R., Batzinger R.P., Miller E.C., Miller J.A., Earhart R.H. Mutagenicity, tumorgenicity, and electrophilic reactivity of the stereoisomeric platinum(II) complexes of 1,2-diaminocyclohexane. Cancer Res. 41:1981;4368-4377.
5. Burnouf D., Daune M., Fuchs R.P.P. Spectrum of cisplatin-induced mutations in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 84:1987;3758-3762.
6. Bubley G.J., Ashburner B.P., Teicher B.A. Spectrum of cis-diamminedichloroplatinum(II)-induced mutations in a shuttle vector propagated in human cells. Mol. Carcinogen. 4:1991;397-406.
7. Vaisman A., Varchenko M., Umar A., Kunkel T.A., Risinger J.I., Barrett J.C., Hamilton T.C., Chaney S.G. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res. 58:1998;3579-3585.
8. Gibbons G.R., Kaufmann W.K., Chaney S.G. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells. Carcinogenesis. 12:1991;2253-2257.
9. Villani G., Hubscher U., Butour J.-L. Sites of termination of in vitro DNA synthesis on cis-diamminedichloroplatinum(II) treated single-stranded DNA: a comparison between E. coli DNA polymerase I and eukaryotic DNA polymerase α Nucl. Acid. Res. 16:1988;4407-4417.
10. Hoffmann J.-S., Pillaire M.-J., Maga G., Podust V., Hubscher U., Villani G. DNA polymerase β bypasses in vitro a single d(GpG)-cisplatin adduct placed on codon 13 of the HRAS gene. Proc. Natl. Acad. Sci. U.S.A. 92:1995;5356-5360.
11. Hoffmann J.-S., Pillaire M.J., Garcia-Estefania D., Lapalu S., Villani G. In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase β and human immunodeficiency virus type I reverse transcriptase is highly mutagenic. J. Biol. Chem. 271:1996;15386-15392.
12. Vaisman A., Chaney S.G. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase β J. Biol. Chem. 275:2000;13017-13025.
13. Canitrot Y., Cazaux C., Frechet M., Bouayadi K., Lesca C., Salles B., Hoffmann J.-S. Overexpression of DNA polymerase β in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc. Natl. Acad. Sci. U.S.A. 95:1998;12586-12590.
14. Canitrot Y., Frechet M., Servant L., Cazaux C., Hoffmann J.-S. Overexpression of DNA polymerase β: a genomic instability enhancer process. FASEB J. 13:1999;1107-1111.
15. Srivastava D.K., Husain I., Arteaga C.L., Wilson S.H. DNA polymerase β expression differences in selected human tumors and cell lines. Carcinogenesis. 20:1999;1049-1054.
16. Scanlon K.J., Kashani-Sabet M., Miyachi H. Differential gene expression in human cancer cells resistant to cisplatin. Cancer Invest. 7:1989;563-569.
17. Kashani-Sabet M., Lu Y., Leong L., Haedicke K., Scanlon K.J. Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracil. Eur. J. Cancer. 26:1990;383-390.
18. Johnson R.E., Prakash S., Prakash L. Requirement of DNA polymerase activity of yeast Rad30 protein for its biological function. J. Biol. Chem. 274:1999;15975-15977.
19. Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., Araki M., Iwai S., Takio K., Hanaoka F. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η Nature. 399:1999;700-704.
20. Roush A.A., Suarez M., Friedberg E.C., Radman M., Siede W. Deletion of the Saccharomyces cerevisiae gene RAD30 encoding an Escherichia coli DinB homolog confers UV radiation sensitivity and altered mutability. Mol. Gen. Genet. 257:1998;686-692.
21. Johnson R.E., Kondratick C.M., Prakash S., Prakash L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science. 285:1999;263-265.
22. Masutani C., Araki M., Yamada A., Kusumoto R., Nogimori T., Maekawa T., Iwai S., Hanaoka F. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. EMBO J. 18:1999;3491-3501.
23. Masutani C., Kusumoto R., Iwai S., Hanaoka F. Mechanisms of accurate translesion synthesis by human DNA polymerase η EMBO J. 19:2000;3100-3109.
24. Vaisman A., Masutani C., Hanaoka F., Chaney S.G. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase η Biochemistry. 39:2000;4575-4580.
25. Nelson J.R., Lawrence C.W., Hinkle D.C. Thymine-thymine dimer bypass by yeast DNA polymerase ζ Science. 272:1996;1646-1649.
26. Tissier A., Frank E.G., McDonald J.P., Iwai S., Hanaoka F., Woodgate R. Misinsertion and bypass of thymine-thymine dimers by human DNA polymerase ι EMBO J. 19:2000;5259-5266.
27. Vaisman A., Lim S.E., Patrick S.M., Copeland W.C., Hinkle D.C., Turchi J.J., Chaney S.G. Effect of DNA Polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts. Biochemistry. 38:1999;11026-11039.
28. Ohashi E., Ogi T., Kusumoto R., Iwai S., Masutani C., Hanaoka F., Ohmori H. Error-prone bypass of certain DNA lesions by the human DNA polymerase κ Genes Dev. 14:2000;1589-1594.
29. McDonald J.P., Tissier A., Frank E.G., Iwai S., Hanaoka F., Woodgate R. DNA polymerase ι and related Rad30-like enzymes. Philos. Trans. R. Soc. Lond. B. 356:2001;53-60.
30. Mamenta E.L., Poma E.E., Kaufmann W.K., Delmastro D.A., Grady H.L., Chaney S.G. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res. 54:1994;3500-3505.
31. Beard W.A., Wilson S.H. Purification and domain-mapping of mammalian DNA polymerase β Methods Enzymol. 262:1995;98-107.
32. 2. J. Am. Chem. Soc. 104:1982;5793-5795.
33. Kunkel T.A. Frameshift mutagenesis by eucaryotic DNA polymerases in vitro. J. Biol. Chem. 261:1986;13581-13587.
34. Matsuda T., Bebenek K., Masutani C., Hanaoka F., Kunkel T.A. Low fidelity DNA synthesis by human DNA polymerase η Nature. 404:2000;1011-1013.
35. Osheroff W.P., Beard W.A., Yin S., Wilson S.H., Kunkel T.A. Minor groove interactions at the DNA polymerase β active site modulate single-base deletion error rates. J. Biol. Chem. 275:2000;28033-28038.
36. de Boer J.G., Glickman B.W. Sequence specificity of mutations induced by the antitumor drug cisplatin in the CHO aprt gene. Carcinogenesis. 10:1989;1363-1367.
37. Bresson A., Fuchs R.P.P. Lesion bypass in yeast cells: Pol η participates in a multi-DNA polymerase process. EMBO J. 21:2002;3881-3887.
38. Kunkel T.A. The mutational specificity of DNA polymerase β during in vitro DNA synthesis. J. Biol. Chem. 260:1985;5787-5796.
39. Matsuda T., Bebenek K., Masutani C., Rogozin I.B., Hanaoka F., Kunkel T.A. Error rate and specificity of human and murine DNA polymerase η J. Mol. Biol. 312:2001;335-346.
40. Iwamoto M., Mukundan S., Marzilli L.G. DNA adduct formation by platinum anticancer drugs. Insight into an unusual GpG intrastrand cross-link in a hairpin-like DNA oligonucleotide using NMR and distance geometry methods. J. Am. Chem. Soc. 116:1994;6238-6244.
41. Yohannes P.G., Zon G., Doetsch P.W., Marzilli L.G. DNA hairpin formation in adducts with platinum anticancer drugs: gel electrophoresis provides new information and a caveat. J. Am. Chem. Soc. 115:1993;5105-5110.
42. van Bloom S.S.G.E., Yang D., Reedijk J., van der Marel G.A., Wang A.H.J. Structural effect of intra-strand cisplatin cross-link on palindromic DNA sequences. J. Biomol. Struct. Dyn. 13:1996;989-998.
43. Kunkel T.A., Soni A. Mutagenesis by transient misalignment. J. Biol. Chem. 263:1988;14784-14789.